Entity Common Stock, Shares Outstanding of Whitehawk Therapeutics, Inc. from Q2 2011 to Q3 2025

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Whitehawk Therapeutics, Inc. quarterly Entity Common Stock, Shares Outstanding history and change rate from Q2 2011 to Q3 2025.
  • Whitehawk Therapeutics, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 04 Nov 2025 was 47.1M shares, a 91.2% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Change (%)

Whitehawk Therapeutics, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 47.1M +22.5M +91.2% 04 Nov 2025 10-Q 06 Nov 2025
Q2 2025 47.1M +22.5M +91.5% 04 Aug 2025 10-Q 07 Aug 2025
Q1 2025 46.8M +22.2M +90.5% 24 Mar 2025 10-K 28 Mar 2025
Q3 2024 24.6M +122K +0.5% 01 Nov 2024 10-Q 06 Nov 2024
Q2 2024 24.6M +95K +0.39% 02 Aug 2024 10-Q 07 Aug 2024
Q1 2024 24.6M +117K +0.48% 08 Mar 2024 10-K 13 Mar 2024
Q3 2023 24.5M +131K +0.54% 03 Nov 2023 10-Q 08 Nov 2023
Q2 2023 24.5M +3.5M +16.7% 04 Aug 2023 10-Q 09 Aug 2023
Q1 2023 24.4M +3.51M +16.8% 23 Mar 2023 10-K 29 Mar 2023
Q3 2022 24.4M +3.5M +16.8% 04 Nov 2022 10-Q 09 Nov 2022
Q2 2022 21M -26.6M -55.9% 05 Aug 2022 10-Q 10 Aug 2022
Q1 2022 20.9M -26.4M -55.8% 11 Mar 2022 10-K 17 Mar 2022
Q3 2021 20.9M -26.2M -55.7% 05 Nov 2021 10-Q 10 Nov 2021
Q2 2021 47.7M +5.59M +13.3% 09 Aug 2021 10-Q 11 Aug 2021
Q1 2021 47.3M +6.73M +16.6% 08 Mar 2021 10-K 11 Mar 2021
Q3 2020 47.1M +6.52M +16.1% 06 Nov 2020 10-Q 10 Nov 2020
Q2 2020 42.1M +1.48M +3.65% 10 Aug 2020 10-Q 12 Aug 2020
Q1 2020 40.6M 0 0% 09 Mar 2020 10-K 16 Mar 2020
Q3 2019 40.6M 0 0% 06 Nov 2019 10-Q 07 Nov 2019
Q2 2019 40.6M +8.15K +0.02% 06 Aug 2019 10-Q 08 Aug 2019
Q1 2019 40.6M +13.4M +49.5% 01 Mar 2019 10-K 07 Mar 2019
Q3 2018 40.6M +13.5M +49.9% 07 Nov 2018 10-Q 07 Nov 2018
Q2 2018 40.6M +13.5M +49.9% 14 Aug 2018 10-Q 14 Aug 2018
Q1 2018 27.1M +22.1M +443% 08 Mar 2018 10-K 15 Mar 2018
Q3 2017 27.1M +22.1M +441% 09 Nov 2017 10-Q 13 Nov 2017
Q2 2017 27.1M +22.1M +441% 10 Aug 2017 10-Q 10 Aug 2017
Q1 2017 5M 0 0% 07 Mar 2017 10-K 07 Mar 2017
Q3 2016 5M 0 0% 14 Nov 2016 10-Q 14 Nov 2016
Q2 2016 5M 0 0% 16 May 2016 10-Q 16 May 2016
Q1 2016 5M 0 0% 30 Mar 2016 10-K 30 Mar 2016
Q3 2015 5M 0 0% 13 Nov 2015 10-Q 13 Nov 2015
Q2 2015 5M 0 0% 13 Aug 2015 10-Q 13 Aug 2015
Q1 2015 5M 0 0% 27 Feb 2015 10-K 27 Feb 2015
Q3 2014 5M 0 0% 14 Nov 2014 10-Q 14 Nov 2014
Q2 2014 5M 0 0% 14 Aug 2014 10-Q 14 Aug 2014
Q1 2014 5M 0 0% 31 Mar 2014 10-K 31 Mar 2014
Q3 2013 5M 0 0% 14 Nov 2013 10-Q 14 Nov 2013
Q2 2013 5M 0 0% 14 Aug 2013 10-Q 14 Aug 2013
Q1 2013 5M 0 0% 28 Mar 2013 10-K 28 Mar 2013
Q3 2012 5M 0 0% 14 Nov 2012 10-Q 14 Nov 2012
Q2 2012 5M 0 0% 14 Aug 2012 10-Q 14 Aug 2012
Q1 2012 5M 15 May 2012 10-Q 15 May 2012
Q4 2011 0 31 Dec 2011 10-K 30 Mar 2012
Q3 2011 5M 14 Nov 2011 10-Q 14 Nov 2011
Q2 2011 5M 09 Aug 2011 10-Q 15 Aug 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.